Evolent Health Inc (NYSE:EVH) shares, rose in value on Wednesday, June 18, with the stock price up by 1.88% to the previous day’s close as strong demand from buyers drove the stock to $8.65.
Actively observing the price movement in the last trading, the stock closed the session at $8.49, falling within a range of $8.355 and $8.83. The value of beta (5-year monthly) was 0.885. Referring to stock’s 52-week performance, its high was $33.63, and the low was $7.06. On the whole, EVH has fluctuated by 0.35% over the past month.
With the market capitalization of Evolent Health Inc currently standing at about $1.02 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that EVH’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of EVH currently trading nearly 7.05% and -3.02% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.08, while the 7-day volatility ratio is showing 2.69% which for the 30-day chart, stands at 5.00%. Furthermore, Evolent Health Inc (EVH)’s beta value is 0.88, and its average true range (ATR) is 0.46.
A comparison of Evolent Health Inc (EVH) with its peers suggests the former has fared considerably weaker in the market. EVH showed an intraday change of 1.88% in last session, and over the past year, it shrunk by -60.08%%.
Data on historical trading for Evolent Health Inc (NYSE:EVH) indicates that the trading volumes over the past 10 days have averaged 1.74 and over the past 3 months, they’ve averaged 2.17 million. According to company’s latest data on outstanding shares, there are 115.86 million shares outstanding.
Nearly 2.65% of Evolent Health Inc’s shares belong to company insiders and institutional investors own 108.95% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 17.46 million shares as on 2025-05-30, resulting in a short ratio of 7.97. According to the data, the short interest in Evolent Health Inc (EVH) stood at 1505.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 16.75 million. The stock has fallen by -23.11% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EVH stock heading into the next quarter.
